How much does it cost to obtain and use a U.S. patent? The depends who you ask. The price to obtain an invention right can
Tag: litigation
U.S. patent litigation awards are highest since 2014; two cases accounted for 64% of the total damages; half were under $10M
$1.4 billion dollars was awarded last year in patent damages, the most since 2014. Two cases were responsible for about two-thirds of that amount or
IPCU readers can save $200 on IP Dealmakers Forum Nov 6-8 in NY
Patent monetization is alive and improving. Look no further than the 5th annual IP Dealmakers Forum, which will attract the top players in IP licensing,
Pace of patent litigation declines; 2018 applications still flat
Early indications are that U.S. patent litigation for 2018 is on track to be among the lowest in since 2005. So far in 2018, approximately
Fixing the patent system/ promoting jobs is focus of Capitol Hill event
An increasing number of experts say the U.S. has lost its edge in the battle to secure and defend meaningful patents that stimulate competition. It
Philanthropist & patent licensing pioneer, Eugene Lang, dead at 98
One of America’s most successful and charitable patent licensing strategists passed away last week. Eugene M. Lang, describe as “an American folk hero” for his
PTAB fairness data is misleading, say more patent holders
Not all patent owners agree the Patent Trial and Appeal Board (PTAB) is a fairer forum for vetting patent quality today. While some believe that
Attorney-investor is willing to share patent filing costs & risks with clients
Many law firms still seek to participate in the outcome of clients’ patent litigation, but few are willing to share the cost of obtaining and
Record 20.4% move in 3Q for Public IP company stock index (PIPX)
Public IP licensing companies (PIPCOs) are very much alive and some company shares are doing surprisingly well, despite increased obstacles to patent licensing. PIPX
The impact of higher patent licensing hurdles may not be fully understood
Most patent holders would agree that licensing patents for revenue has gone from bad to awful — from difficult less than a decade ago, to
Jury awards Merck $200M in patent damages, 10% of what it had sought
A California jury has awarded pharmaceutical drug company Merck $200 million, a fraction of what it had sought, for infringement of two of its patents
Responsible Patent Licensing is focus of Wall Street event
Not all patent licensing businesses are alike. “NPE 2016: The Business of Responsible Licensing,” scheduled for March 22 at the Convene conference in New York,
ipcloseup.com 